S. Gesase

发表

A phase 3 trial of RTS,S/AS01 malaria vaccine in African infants.

Kwaku Poku Asante, M. Tanner, K. Marsh, 2012, The New England journal of medicine.

Immunogenicity of the RTS,S/AS01 malaria vaccine and implications for duration of vaccine efficacy: secondary analysis of data from a phase 3 randomised controlled trial

Kwaku Poku Asante, R. Verity, A. Ghani, 2015 .

High Resistance of Plasmodium falciparum to Sulphadoxine/Pyrimethamine in Northern Tanzania and the Emergence of dhps Resistance Mutation at Codon 581

D. Chandramohan, B. Greenwood, S. Gesase, 2009, PloS one.

Cost Implications of Improving Malaria Diagnosis: Findings from North-Eastern Tanzania

L. Conteh, D. Chandramohan, S. Gesase, 2010, PloS one.

Severe falciparum malaria is one of the main causes of death in African children, who account for >85% of the worldwide

S. Gesase, G. Mtove, L. Seidlein, 2018 .

Population Pharmacokinetics of Intramuscular Artesunate in African Children With Severe Malaria: Implications for a Practical Dosing Regimen

S. Gesase, M. Lemnge, N. Day, 2013, Clinical pharmacology and therapeutics.

Population Pharmacokinetic and Pharmacodynamic Properties of Intramuscular Quinine in Tanzanian Children with Severe Falciparum Malaria

S. Gesase, M. Lemnge, N. Day, 2012, Antimicrobial Agents and Chemotherapy.

Efficacy of RTS,S/AS01E vaccine against malaria in children 5 to 17 months of age.

M. Demoitié, K. Marsh, C. Drakeley, 2008, The New England journal of medicine.

Efficacy and Tolerability Outcomes of a Phase II, Randomized, Open-Label, Multicenter Study of a New Water-Dispersible Pediatric Formulation of Dihydroartemisinin-Piperaquine for the Treatment of Uncomplicated Plasmodium falciparum Malaria in African Infants

Q. Bassat, A. Mtoro, U. d’Alessandro, 2017, Antimicrobial Agents and Chemotherapy.

Attributable risk factors for asymptomatic malaria and anaemia and their association with cognitive and psychomotor functions in schoolchildren of north-eastern Tanzania

J. Lusingu, S. Gesase, M. Alifrangis, 2022, PloS one.

Weight change during the first week of life and a new method for retrospective prediction of birthweight among exclusively breastfed newborns

S. Gesase, O. Abdul, T. Scheike, 2022, Acta obstetricia et gynecologica Scandinavica.

ARTICLES AND COMMENTARIES

J. Smith, N. Reich, K. Silamut, 2011 .

Transmission of Cryptosporidium Species Among Human and Animal Local Contact Networks in Sub-Saharan Africa: A Multicountry Study

F. Conraths, A. Adegnika, P. Kremsner, 2020, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Defining Falciparum-Malaria-Attributable Severe Febrile Illness in Moderate-to-High Transmission Settings on the Basis of Plasma PfHRP2 Concentration

K. Silamut, S. Gesase, N. Day, 2012, The Journal of infectious diseases.

Comparison of artesunate–mefloquine and artemether–lumefantrine fixed-dose combinations for treatment of uncomplicated Plasmodium falciparum malaria in children younger than 5 years in sub-Saharan Africa: a randomised, multicentre, phase 4 trial

A. Mtoro, B. Ogutu, J. Lusingu, 2016, The Lancet. Infectious Diseases.

De ﬁ ning Falciparum-Malaria-Attributable Severe Febrile Illness in Moderate-to-High Transmission Settings on the Basis of Plasma Pf HRP2 Concentration

K. Silamut, S. Gesase, N. White, 2012 .

Genetic Diversity and Protective Efficacy of the RTS,S/AS01 Malaria Vaccine.

Trevor Bedford, Kevin Marsh, Elizabeth M. Ryan, 2015, The New England journal of medicine.

Is Housing Quality Associated with Malaria Incidence among Young Children and Mosquito Vector Numbers? Evidence from Korogwe, Tanzania

T. Bousema, D. Chandramohan, S. Gesase, 2014, PloS one.

First results of phase 3 trial of RTS,S/AS01 malaria vaccine in African children.

Pedro Alonso, Trudie Lang, Bernhards Ogutu, 2011, The New England journal of medicine.

Seroprevalence of SARS-CoV-2 antibodies among children and adolescents recruited in a malariometric survey in north-eastern Tanzania July 2021

J. Lusingu, S. Gesase, Anangisye Malabeja, 2022, BMC Infectious Diseases.

IgG Responses to Anopheles gambiae Salivary Antigen gSG6 Detect Variation in Exposure to Malaria Vectors and Disease Risk

T. Bousema, T. Theander, C. Drakeley, 2012, PloS one.

Evaluation of a PfHRP2 and a pLDH-based Rapid Diagnostic Test for the Diagnosis of Severe Malaria in 2 Populations of African Children

K. Silamut, S. Gesase, Sue J Lee, 2011, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

The choice of reference chart affects the strength of the association between malaria in pregnancy and small for gestational age: an individual participant data meta-analysis comparing the Intergrowth-21 with a Tanzanian birthweight chart

T. Theander, S. Gesase, O. Abdul, 2022, Malaria Journal.

Risks of Hemolysis in Glucose-6-Phosphate Dehydrogenase Deficient Infants Exposed to Chlorproguanil-Dapsone, Mefloquine and Sulfadoxine-Pyrimethamine as Part of Intermittent Presumptive Treatment of Malaria in Infants

E. Vittinghoff, D. Chandramohan, S. Gesase, 2015, PloS one.

Artesunate versus quinine in the treatment of severe falciparum malaria in African children (AQUAMAT): an open-label, randomised trial

Kamolrat Silamut, Lorenz von Seidlein, Nicholas J White, 2010, The Lancet.

Epidemiology and Antimicrobial Susceptibility of Salmonella enterica Bloodstream Isolates Among Febrile Children in a Rural District in Northeastern Tanzania: A Cross-sectional Study

J. Crump, J. Lusingu, S. Gesase, 2019, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Comparative genomics revealed adaptive admixture in Cryptosporidium hominis in Africa

M. Bahlo, A. Adegnika, P. Kremsner, 2020, Microbial genomics.

Long-term incidence of severe malaria following RTS,S/AS01 vaccination in children and infants in Africa: an open-label 3-year extension study of a phase 3 randomised controlled trial.

H. Tinto, H. Sorgho, I. Valéa, 2019, The Lancet. Infectious diseases.

Protective efficacy and safety of three antimalarial regimens for intermittent preventive treatment for malaria in infants: a randomised, double-blind, placebo-controlled trial

D. Chandramohan, B. Greenwood, S. Gesase, 2009, The Lancet.

Identification of hot spots of malaria transmission for targeted malaria control.

Teun Bousema, Jonathan Cox, Daniel Chandramohan, 2010, The Journal of infectious diseases.

Duration of Protection Against Clinical Malaria Provided by Three Regimens of Intermittent Preventive Treatment in Tanzanian Infants

D. Chandramohan, B. Greenwood, S. Gesase, 2010, PloS one.

Mode of action and choice of antimalarial drugs for intermittent preventive treatment in infants.

D. Chandramohan, B. Greenwood, S. Gesase, 2009, Transactions of the Royal Society of Tropical Medicine and Hygiene.

Rapid Assessment of Malaria Transmission Using Age-Specific Sero-Conversion Rates

A. Ghani, J. Griffin, T. Bousema, 2009, PloS one.

High reinfection rate and treatment failures in children treated with amodiaquine for falciparum malaria in Muheza villages, Northeastern Tanzania.

S. Gesase, M. Lemnge, I. Bygbjerg, 2006, The American journal of tropical medicine and hygiene.

Effectiveness and safety of intermittent preventive treatment for malaria using either dihydroartemisinin-piperaquine or artesunate-amodiaquine in reducing malaria related morbidities and improving cognitive ability in school-aged children in Tanzania: A study protocol for a controlled randomised tr

J. Lusingu, S. Gesase, G. Mtove, 2020, Contemporary clinical trials communications.

Impact of insecticide treated mosquito nets and low dose monthly diethylcarbamazine on lymphatic filariasis infection between 1999 and 2004 in two endemic communities of north-eastern Tanzania.

S. Gesase, M. Lemnge, I. Bygbjerg, 2012, Tanzania journal of health research.

Implementation research of a cluster randomized trial evaluating the implementation and effectiveness of intermittent preventive treatment for malaria using dihydroartemisinin-piperaquine on reducing malaria burden in school-aged children in Tanzania: methodology, challenges, and mitigation

J. Lusingu, S. Gesase, E. Liheluka, 2023, Malaria Journal.

Longitudinal estimation of Plasmodium falciparum prevalence in relation to malaria prevention measures in six sub-Saharan African countries

Kwaku Poku Asante, M. Tanner, C. Drakeley, 2017, Malaria Journal.

Diagnosing Severe Falciparum Malaria in Parasitaemic African Children: A Prospective Evaluation of Plasma PfHRP2 Measurement

C. Karema, K. Maitland, K. Silamut, 2012, PLoS medicine.

Predicting the Clinical Outcome of Severe Falciparum Malaria in African Children: Findings From a Large Randomized Trial

K. Bojang, C. Karema, K. Maitland, 2012, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Phase Iib, Randomized, Double-Blind Trial to Assess the Efficacy, Safety and Immunogenicity of the Candidate Malaria Vaccine Rts,S/As01 in Kenyan and Tanzanian Children

M. Demoitié, K. Marsh, C. Drakeley, 2008 .

Cost-effectiveness of parenteral artesunate for treating children with severe malaria in sub-Saharan Africa.

S. Gesase, N. Day, N. White, 2011, Bulletin of the World Health Organization.

High anti-SARS-CoV-2 seroprevalence among unvaccinated mother–child pairs from a rural setting in north-eastern Tanzania during the second wave of COVID-19

S. Gesase, I. Bygbjerg, G. Mtove, 2022, IJID Regions.

✩ ✩ , ★ , ★ ★

S. Gesase, I. Bygbjerg, G. Mtove, 2022 .

Efficacy of RTS,S/AS01E malaria vaccine and exploratory analysis on anti-circumsporozoite antibody titres and protection in children aged 5–17 months in Kenya and Tanzania: a randomised controlled trial

K. Marsh, C. Drakeley, A. Olotu, 2011, The Lancet. Infectious diseases.

Safety and immunogenicity of the RTS,S/AS01 malaria vaccine in infants and children identified as HIV-infected during a randomized trial in sub-Saharan Africa

Kwaku Poku Asante, M. Tanner, S. Adjei, 2019, Vaccine.

Levels of Plasma Immunoglobulin G with Specificity against the Cysteine-Rich Interdomain Regions of a Semiconserved Plasmodium falciparum Erythrocyte Membrane Protein 1, VAR4, Predict Protection against Malarial Anemia and Febrile Episodes

Thor G. Theander, T. Theander, J. Lusingu, 2006, Infection and Immunity.

Sequence variation does not confound the measurement of plasma PfHRP2 concentration in African children presenting with severe malaria

C. Karema, K. Maitland, K. Silamut, 2012, Malaria Journal.

Effect of monthly intermittent preventive treatment with dihydroartemisinin–piperaquine with and without azithromycin versus monthly sulfadoxine–pyrimethamine on adverse pregnancy outcomes in Africa: a double-blind randomised, partly placebo-controlled trial

K. Otieno, S. Gesase, G. Mtove, 2023, The Lancet.

Safety profile of the RTS,S/AS01 malaria vaccine in infants and children: additional data from a phase III randomized controlled trial in sub-Saharan Africa

Kwaku Poku Asante, M. Tanner, S. Adjei, 2019, Human vaccines & immunotherapeutics.

Assessment of severe malaria in a multicenter, phase III, RTS, S/AS01 malaria candidate vaccine trial: case definition, standardization of data collection and patient care

Kwaku Poku Asante, K. Marsh, J. Sacarlal, 2011, Malaria Journal.

Study of enteric pathogens among children in the tropics and effects of prolonged storage of stool samples

U. Schotte, J. Lusingu, S. Gesase, 2021, Letters in applied microbiology.

Plasma Concentration of Parasite DNA as a Measure of Disease Severity in Falciparum Malaria

S. Gesase, N. Day, N. White, 2014, The Journal of infectious diseases.

Haplotypes of the endothelial protein C receptor (EPCR) gene are not associated with severe malaria in Tanzania

T. Theander, J. Lusingu, S. Gesase, 2015, Malaria Journal.

Satisfactory safety and immunogenicity of MSP3 malaria vaccine candidate in Tanzanian children aged 12–24 months

R. Noor, S. Cousens, R. Chilengi, 2009, Malaria Journal.

Effectiveness and safety of intermittent preventive treatment with dihydroartemisinin-piperaquine or artesunate-amodiaquine for reducing malaria and related morbidities in schoolchildren in Tanzania: a randomised controlled trial.

J. Lusingu, S. Gesase, Vito Baraka, 2023, The Lancet. Global health.

Safety of the Malaria Vaccine Candidate, RTS,S/AS01E in 5 to 17 Month Old Kenyan and Tanzanian Children

K. Marsh, C. Drakeley, A. Olotu, 2010, PloS one.

Haplotypes of the endothelial protein C receptor (EPCR) gene are not associated with severe malaria in Tanzania

T. Theander, J. Lusingu, S. Gesase, 2015, Malaria Journal.

Comparison of artesunate–mefloquine and artemether–lumefantrine fixed-dose combinations for treatment of uncomplicated Plasmodium falciparum malaria in children younger than 5 years in sub-Saharan Africa: a randomised, multicentre, phase 4 trial

A. Mtoro, B. Ogutu, J. Lusingu, 2016, The Lancet. Infectious Diseases.

Comparison of artesunate–mefloquine and artemether–lumefantrine fixed-dose combinations for treatment of uncomplicated Plasmodium falciparum malaria in children younger than 5 years in sub-Saharan Africa: a randomised, multicentre, phase 4 trial

A. Mtoro, B. Ogutu, J. Lusingu, 2016, Lancet. Infectious Diseases (Print).

Community perceptions on the effectiveness of herbal medicines and factors associated with their use in managing diarrhoea among under-five children in North-eastern Tanzania

S. Gesase, E. Liheluka, D. Minja, 2023, Tropical Medicine and Health.

Comparison of artesunate–mefloquine and artemether–lumefantrine fixed-dose combinations for treatment of uncomplicated Plasmodium falciparum malaria in children younger than 5 years in sub-Saharan Africa: a randomised, multicentre, phase 4 trial

A. Mtoro, B. Ogutu, J. Lusingu, 2016, The Lancet. Infectious diseases.

Fetal growth and birth weight are independently reduced by malaria infection and curable sexually transmitted and reproductive tract infections in Kenya, Tanzania, and Malawi: A pregnancy cohort study.

S. Gesase, Queen Saidi, M. Alifrangis, 2023, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.

Efficacy of RTS,S/AS01E vaccine against malaria in children 5 to 17 months of age.

M. Demoitié, K. Marsh, A. Olotu, 2008, The New England journal of medicine.

Comparing the roles of community health workers for malaria control and elimination in Cambodia and Tanzania

S. Gesase, A. Dondorp, R. Tripura, 2023, BMJ Global Health.

Immunogenicity of the RTS,S/AS01 malaria vaccine and implications for duration of vaccine efficacy: secondary analysis of data from a phase 3 randomised controlled trial

Kwaku Poku Asante, R. Verity, A. Ghani, 2015, The Lancet. Infectious diseases.